Stocks
Exelixis Financial Statements (EXEL) |
||||||||||
| Exelixissmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 25.02.2020 | 11.02.2021 | 18.02.2022 | 07.02.2023 | 06.02.2024 | 29.10.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 967.8 | 987.5 | 1 435 | 1 611 | 1 830 | 2 020 | |||
| Operating Income, bln rub | 369.5 | 110.1 | 286.7 | 201.5 | 170.9 | 523.7 | ||||
| EBITDA, bln rub | ? | 369.5 | 110.1 | 300.3 | 222.4 | 196.6 | 602.9 | |||
| Net profit, bln rub | ? | 321.0 | 111.8 | 231.1 | 182.3 | 207.8 | 466.9 | |||
| OCF, bln rub | ? | 527.0 | 209.0 | 400.8 | 362.6 | 333.3 | 470.3 | |||
| CAPEX, bln rub | ? | 12.8 | 30.3 | 64.2 | 138.5 | 163.0 | 62.7 | |||
| FCF, bln rub | ? | 514.1 | 178.6 | 336.6 | 224.2 | 170.4 | 457.1 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 565.2 | 841.2 | 1 095 | 1 352 | 1 587 | 1 464 | ||||
| Cost of production, bln rub | 33.1 | 36.3 | 52.9 | 57.9 | 72.5 | 78.0 | ||||
| R&D, bln rub | 337.0 | 547.9 | 693.7 | 891.8 | 1 044 | 906.1 | ||||
| Interest expenses, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 26.3 | ||||
| Assets, bln rub | 1 886 | 2 137 | 2 616 | 3 071 | 2 942 | 2 960 | ||||
| Net Assets, bln rub | ? | 1 686 | 1 879 | 2 211 | 2 488 | 2 264 | 2 275 | |||
| Debt, bln rub | 50.7 | 49.1 | 51.3 | 190.2 | 189.9 | 194.4 | ||||
| Cash, bln rub | 852.2 | 1 207 | 1 467 | 1 308 | 995.3 | 1 189 | ||||
| Net debt, bln rub | -801.5 | -1 157 | -1 416 | -1 118 | -805.4 | -994.7 | ||||
| Ordinary share price, rub | 17.0 | 20.1 | 18.3 | 16.0 | 24.0 | 20.1 | ||||
| Number of ordinary shares, mln | 302.6 | 308.3 | 314.9 | 321.5 | 318.2 | 285.6 | ||||
| Market cap, bln rub | 5 147 | 6 187 | 5 756 | 5 157 | 7 632 | 5 747 | ||||
| EV, bln rub | ? | 4 345 | 5 030 | 4 340 | 4 039 | 6 827 | 4 752 | |||
| Book value, bln rub | 1 622 | 1 815 | 2 147 | 2 425 | 2 200 | 2 212 | ||||
| EPS, rub | ? | 1.06 | 0.36 | 0.73 | 0.57 | 0.65 | 1.63 | |||
| FCF/share, rub | 1.70 | 0.58 | 1.07 | 0.70 | 0.54 | 1.60 | ||||
| BV/share, rub | 5.36 | 5.89 | 6.82 | 7.54 | 6.92 | 7.74 | ||||
| EBITDA margin, % | ? | 38.2% | 11.1% | 20.9% | 13.8% | 10.7% | 29.8% | |||
| Net margin, % | ? | 33.2% | 11.3% | 16.1% | 11.3% | 11.4% | 23.1% | |||
| FCF yield, % | ? | 9.99% | 2.89% | 5.85% | 4.35% | 2.23% | 7.95% | |||
| ROE, % | ? | 19.0% | 5.95% | 10.5% | 7.33% | 9.18% | 20.5% | |||
| ROA, % | ? | 17.0% | 5.23% | 8.83% | 5.93% | 7.06% | 15.8% | |||
| P/E | ? | 16.0 | 55.3 | 24.9 | 28.3 | 36.7 | 12.3 | |||
| P/FCF | 10.0 | 34.6 | 17.1 | 23.0 | 44.8 | 12.6 | ||||
| P/S | ? | 5.32 | 6.27 | 4.01 | 3.20 | 4.17 | 2.84 | |||
| P/BV | ? | 3.17 | 3.41 | 2.68 | 2.13 | 3.47 | 2.60 | |||
| EV/EBITDA | ? | 11.8 | 45.7 | 14.5 | 18.2 | 34.7 | 7.88 | |||
| Debt/EBITDA | -2.17 | -10.5 | -4.71 | -5.03 | -4.10 | -1.65 | ||||
| R&D/CAPEX, % | 2 626% | 1 805% | 1 080% | 644.1% | 640.7% | 1 446% | ||||
| CAPEX/Revenue, % | 1.33% | 3.07% | 4.48% | 8.59% | 8.90% | 3.10% | ||||
| Exelixis shareholders | ||||||||||
